{"id":55119,"date":"2025-10-26T14:08:58","date_gmt":"2025-10-26T18:08:58","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/novartis-acquires-avidity-biosciences-in-12-billion-deal-palantir-to-partner-with-polish-defence-ministry\/55119\/"},"modified":"2025-10-26T14:08:58","modified_gmt":"2025-10-26T18:08:58","slug":"novartis-acquires-avidity-biosciences-in-12-billion-deal-palantir-to-partner-with-polish-defence-ministry","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-acquires-avidity-biosciences-in-12-billion-deal-palantir-to-partner-with-polish-defence-ministry\/55119\/","title":{"rendered":"Novartis Acquires Avidity Biosciences in $12 Billion Deal; Palantir to Partner with Polish Defence Ministry"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novartis AG<\/strong> has agreed to acquire <strong>Avidity Biosciences<\/strong> in a significant <strong>$12 billion<\/strong> deal, paying <strong>$72 per share<\/strong>, representing a <strong>46% premium<\/strong>, to bolster its late-stage neuroscience pipeline and expand its presence in RNA therapeutics.<\/li>\n<li><strong>Palantir Technologies (<a href=\"\/stock\/PLTR\">PLTR<\/a>)<\/strong> is set to sign a letter of intent with the <strong>Polish Defence Ministry<\/strong> on Monday, signaling deepening cooperation in the defense sector.<\/li>\n<li>Major <strong>Hurricane Melissa<\/strong> is under investigation by an Air Force Hurricane Hunter, with life-threatening floods anticipated in Jamaica and Southern Hispaniola.<\/li>\n<li>The <strong>Rapid Support Forces (RSF)<\/strong> claim a significant military achievement in Al-Fashir, Sudan, by controlling the army&#39;s command, marking a critical turning point in the ongoing conflict.<\/li>\n<\/ul>\n<p>Swiss pharmaceutical giant <strong>Novartis AG (<a href=\"\/stock\/NVS\">NVS<\/a>)<\/strong> has announced a definitive agreement to acquire <strong>Avidity Biosciences (<a href=\"\/stock\/RNA\">RNA<\/a>)<\/strong> for <strong>$12 billion<\/strong>. The acquisition price of <strong>$72 per share<\/strong> represents a substantial <strong>46% premium<\/strong> over Avidity&#39;s recent trading levels. This strategic move aims to significantly strengthen Novartis&#39;s late-stage neuroscience pipeline and expand its capabilities in the rapidly evolving field of RNA therapeutics. Ahead of the closing, Avidity Biosciences is expected to spin off its early-stage precision cardiology assets.<\/p>\n<p>The acquisition aligns with Novartis&#39;s aggressive deal-making strategy to bolster its drug pipeline and offset looming patent cliffs for some of its best-selling drugs. Avidity Biosciences, a biotech firm focused on rare diseases, has three drugs in clinical trials targeting various forms of muscular dystrophy. Its promising assets include delpacibart zotadirsen (del-zota), an investigational antibody-oligonucleotide conjugate (AOC) for Duchenne muscular dystrophy, which has shown encouraging results in early trials and received Breakthrough Therapy designation from the FDA. Analysts have noted Avidity&#39;s leadership in muscular RNAi therapies, identifying potential multi-billion dollar opportunities in neuromuscular indications that currently lack disease-modifying treatments. The news of a potential takeover had previously caused Avidity&#39;s shares to surge significantly.<\/p>\n<p>In other corporate news, <strong>Palantir Technologies Inc. (<a href=\"\/stock\/PLTR\">PLTR<\/a>)<\/strong> is scheduled to sign a letter of intent on Monday with the <strong>Polish Defence Ministry<\/strong>. While specific details of the agreement were not immediately disclosed, cooperation between Palantir and the Polish Defence Ministry reportedly began in December of last year. This development suggests a deepening partnership between the data analytics software company and Poland&#39;s defense sector.<\/p>\n<p>Meanwhile, a significant weather event is unfolding in the Caribbean. Air Force Hurricane Hunters are currently investigating Major <strong>Hurricane Melissa<\/strong>, which poses a severe threat to Jamaica and Southern Hispaniola. The hurricane is expected to bring life-threatening flash floods and landslides to these regions. As of Sunday, Hurricane Melissa was sustaining winds of 140 mph, classifying it as a Category 4 hurricane, and was expected to strengthen further.<\/p>\n<p>On the geopolitical front, an advisor to the leader of the &quot;Rapid Support Forces&quot; (RSF) in Sudan has claimed a major military achievement in Al-Fashir. The advisor stated that the RSF has gained control of the army&#39;s command in the city, describing it as a &quot;very important turning point&quot; and facilitating advances on other areas. The advisor also indicated that over 40,000 soldiers were present in Al-Fashir. This development comes amidst a tightening siege by the paramilitary RSF on El-Fasher, which has been the epicenter of intense fighting and a dire humanitarian crisis for over a year. The UN has repeatedly raised alarms about the rapidly deteriorating situation and the devastating impact on civilians in the besieged city.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novartis AG has agreed to acquire Avidity Biosciences in a significant $12 billion deal, paying $72 per share, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[13472,13476,5230,13477,5777,13478,5951,13479,6016,13480,6314,7773,8560,9637,11173],"class_list":["post-55119","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-avidity-biosciences","tag-rna-therapeutics","tag-defense","tag-palantir-technologies","tag-novartis","tag-hurricane-melissa","tag-mergers-and-acquisitions","tag-neuroscience","tag-biotechnology","tag-rna-stock-rna","tag-poland","tag-pltr-stock-pltr","tag-nvs-stock-nvs","tag-rsf","tag-aoc"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=55119"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55119\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=55119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=55119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=55119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}